2025 AIChE Annual Meeting

(157c) Optimization of Charged Membranes Enhances Ultrafiltration Performance during Concentration of siRNA for Gene Therapy Applications

Authors

Ken Qian, Eli Lilly
McKensie Mason, Eli Lilly
Andrew Zydney, Pennsylvania State University
Small interfering RNA (siRNA) suppresses the production of proteins involved in disease by binding to the target mRNA via complementary base pairing. siRNA therapeutics have been successfully developed for treatment of neurologic disorders, atherosclerosis, and liver disease among others. These drugs typically need to be formulated at very high concentrations to deliver the required therapeutic dose in a single subcutaneous injection. Recent work in our lab has demonstrated that ultrafiltration with negatively charged membranes could concentrate siRNA to 180 mg/mL, more than 3 times the maximum concentration achieved using commercial (non-modified) cellulose membranes. This dramatic improvement in performance was due to the reduction in membrane fouling and concentration polarization arising from the electrostatic repulsion between the negatively charged membranes and the negatively charged siRNA.

The present study is focused on exploring the effects of reaction conditions and ligand properties on the ultrafiltration performance during siRNA concentration. A series of charge-modified cellulose membranes were produced by chemical modification with sulfonic acid functionalities over different reaction times (8, 24 and 48 h), ligand concentrations (1, 2 and 4 M), and spacer arm lengths (varying the number of carbons between the sulfonic acid group and the surface between 2, 3 and 4 carbon atoms). Ultrafiltration experiments were performed over a range of feed siRNA concentrations in stirred ultrafiltration cells at constant / uniform transmembrane pressure (TMP). Membranes were characterized using X-ray Photoelectron Spectroscopy (to evaluate the Sulfur content) and using zeta potential measurements (to evaluate the effective membrane charge). The ligand charge density was higher at higher ligand concentrations and longer reaction times; however, the highest final siRNA concentration achieved during ultrafiltration was obtained using intermediate charging conditions (2 M ligand for 24 h). Membranes with higher degrees of modification showed better siRNA retention but suffered from lower initial fluxes, likely due to pore crowding / blockage effects. Increasing the spacer arm length from 2 to 4 carbons reduced the measured surface zeta potential from -13 to -10 mV, although the membrane with the longer spacer arm showed better performance during siRNA ultrafiltration. These results provide important insights into the factors controlling the performance and optimization of these novel charged ultrafiltration membranes for processing siRNA therapeutics.